Optimed

What Optimed does

Optimed Medizinische Instrumente GmbH is a German medical device manufacturer founded in 1996 (per corporate history) and headquartered in Ettlingen, Germany. The company develops, manufactures, and globally distributes minimally invasive medical devices across three core therapeutic areas: vascular interventions (arterial and venous stenting), urology (ureteral stents, stone management, nephrostomy, single-use ureterorenoscopes), and gastroenterology (biliary and pancreatic endoprostheses under the GastroSoft brand). Its flagship product families include the sinus-XL arterial stent system, the sinus-Venous and sinus-Obliquus purpose-built venous stent systems (including indications for May-Thurner syndrome), the Tentos 4F low-profile peripheral stent, and the NyloTrack+ PTA balloon catheter. Manufacturing is anchored at the Ettlingen headquarters with a state-of-the-art clean room facility opened in 2021.

The company operates a B2B medical device business model, selling hardware products through an international distributor network covering more than 70 countries across Europe, Latin America, Asia-Pacific, the Middle East, and Africa. Pricing is quote-based to healthcare institutions, with multi-year distributor contracts. Optimed's customer base is fragmented across interventional radiology, vascular surgery, urology, and gastroenterology physician segments, with no disclosed end-customer concentration. Following a multi-step acquisition announced in January 2026 by Hong Kong-listed Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX:2190), Optimed now operates as a subsidiary within a unified platform, with CEO Rüdiger Hausherr continuing in his role and reporting to Zylox-Tonbridge Chairman and CEO Jonathon Zhong Zhao.

Revenue is not publicly disclosed. With a stated workforce of 200+ employees across headquarters, production sites, and the international sales network, and a 29-year operating history with mature, regulatory-cleared product lines distributed across 70+ countries, the business operates at meaningful scale within its niche. The Zylox-Tonbridge acquisition is structured to integrate Optimed's European R&D, manufacturing, and commercial footprint with Zylox-Tonbridge's neuro- and peripheral vascular interventional portfolio, with operational synergies expected from combining German manufacturing with the acquirer's China-based operations and accelerating international expansion beyond mainland China.

Name

Optimed

Legal name

optimed Medizinische Instrumente GmbH

Website

https://optimed.com

Company type

Private

Founded year

1996

Operating status

Acquired

Headcount range

51–100 employees

Short description

Optimed Medizinische Instrumente GmbH is a German medical device manufacturer specializing in minimally invasive vascular (arterial and venous stents), urology, and gastroenterology products, sold B2B through a distributor network spanning 70+ countries, and now operating as a subsidiary of Hong Kong-listed Zylox-Tonbridge.

Ownership category

akta.pro rank

Product category

Minimally Invasive Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE)

akta.pro secondary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Minimally invasive devices
• Vascular stent systems
• Endourology devices
• Peripheral vascular interventions
• Medical device manufacturing

Headquarters

HQ city

Ettlingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Device Sales: Hardware sales of minimally invasive medical devices including vascular stents, urology products, and gastroenterology devices. Revenue generated from product sales to healthcare providers through international distribution network.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Optimed designs, manufactures, and globally distributes medical devices for minimally invasive therapy, with a core focus on purpose-built arterial and venous stent systems (sinus-XL, sinus-SuperFlex, sinus-Venous, sinus-Obliquus, Tentos 4F) used in vascular interventions. The portfolio also includes PTA balloon catheters, ureteral stents, stone baskets, nephrostomy devices, single-use ureterorenoscopes, biliary and pancreatic endoprostheses, vertebroplasty cement, and a CO2 angiography set, sold to hospitals and clinicians across vascular surgery, interventional radiology, urology, gastroenterology, and orthopedics/traumatology.

Product overview

Optimed is a German medical device company specializing in minimally invasive therapy products. The portfolio consists of vascular intervention products (arterial and venous stent systems including the sinus-XL, sinus-SuperFlex, sinus-Venous, and sinus-Obliquus families, plus the Tentos 4F and NyloTrack+ balloon catheter), urology products (ureteral stents including OptiSoft and Opti-J variants, stone baskets, nephrostomy catheters, VarioTip accessories, and specialized devices like the Single-use Ureterorenoskope and Exime), gastroenterology products (biliary and pancreatic endoprostheses under the GastroSoft brand), and special products (CO2-Angioset for CO2 angiography and Cemento-MP for vertebroplasty). The company also offers procedural accessories including needles, dilators, sheaths, and adapters. These products serve interventional radiology, vascular surgery, urology, gastroenterology, and orthopedics/traumatology disciplines, with manufacturing and R&D facilities based in Ettlingen, Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• sinus-XL Family Arterial stent system (sinus-XL, sinus-XL 6F, sinus-XL Flex, sinus-Repo-Visual 6F) designed for peripheral and central vascular interventions to restore or maintain vessel patency; sold to interventional radiology and vascular surgery departments.
• sinus-SuperFlex Family SuperFlex arterial stent systems (sinus-SuperFlex-635, -535, -DS) for peripheral vascular applications, sold to vascular surgery and interventional radiology teams.
• Tentos 4F Flexible open-cell stent with true 4F application system, very small crossing profile, and a unique range of stent sizes for small vessels and superficial femoral artery (SFA); sold to vascular interventionalists.
• sinus-Venous Stent System Dedicated venous stent system engineered for the unique challenges of venous diseases including May-Thurner syndrome and venous obstructions; designed to offer durable stents that improve patient quality of life. Sold to vascular surgery and interventional radiology departments.
• sinus-Obliquus Stent System Venous stent system designed for oblique anatomy and challenging venous conditions; sold to vascular specialists treating complex venous disease.
• NyloTrack+ Semi-compliant PTA (percutaneous transluminal angioplasty) balloon catheter for peripheral vascular interventions; sold to interventional radiology and vascular surgery teams.
• OptiSoft Ureteral Stent Family Ureteral stent product line for kidney drainage and renal transplantation applications, including specialized renal transplantation stents and OptiPur variants; sold to urology departments.
• Opti-J Ureteral Stent J-shaped ureteral stent configuration designed for specialized urinary drainage applications; sold to urology departments.
• Mono-J Ureteral Stent Mono-J ureteral stent for urinary drainage applications; sold to urology departments.
• Pediatric Ureteral Stent Small-sized ureteral stents designed specifically for pediatric urological applications; sold to pediatric urology teams.
• Stone Baskets Urological stone management devices for capturing and removing urinary stones during endourological procedures; sold to urology departments.
• Nephrostomy Products Percutaneous nephrostomy products for kidney drainage procedures; sold to interventional radiology and urology departments.
• Ureteral Catheters Catheters for ureteral access and drainage in urological procedures; sold to urology departments.
• VarioTip / VarioTip Premium Accessory tip devices (standard and Premium versions) supporting urological procedures; sold to urology departments.
• Single-use Ureterorenoskope Disposable (single-use) ureterorenoscope for direct visualization of the ureter and kidney during endourological procedures; sold to urology departments.
• Zystoskope Cystoscope device for bladder examination and related urological procedures; sold to urology departments.
• GastroSoft Biliary Endoprosthesis Biliary stent for maintaining bile duct patency during ERCP (endoscopic retrograde cholangiopancreatography) procedures; sold to gastroenterology departments.
• GastroSoft Pancreatic Endoprosthesis Pancreatic endoprosthesis for pancreatic duct drainage during ERCP procedures; sold to gastroenterology departments.
• CO2-Angioset Carbon dioxide angiography set for CO2-based vascular imaging as an alternative to iodinated contrast media; sold to interventional radiology and vascular surgery departments.
• Cemento-MP Vertebroplasty cement product for the treatment of vertebral compression fractures; sold to orthopedic and trauma surgery departments.
• Endosil Endoscopic device for closure or sealing applications during gastroenterology procedures; sold to gastroenterology departments.

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Zylox-Tonbridge Medical Technology Co., Ltd.coreStrategic or Co-development Partner · 16 January 2026Hong Kong-listed Zylox-Tonbridge (HKEX:2190) announced strategic investment in Germany-based Optimed Medizinische Instrumente GmbH. The multi-step deal aims to accelerate international expansion with Optimed's nearly 30-year operating history and sales/service network spanning 70+ countries. Transaction creates unified platform combining R&D, manufacturing, and commercialization, with Optimed's European manufacturing base expected to deliver operational synergies and support reliable global supply. Financial terms not disclosed.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Penumbra: US-listed vascular intervention specialist with peripheral and venous thrombectomy products, an adjacent comparable in the minimally invasive peripheral vascular space where Optimed competes.
• Biotronik: Privately held German medical device company specializing in vascular intervention (including peripheral stents), directly comparable as a fellow mid-sized German medtech with overlapping peripheral vascular product lines.
• Cook Medical: Privately held US medical device manufacturer specializing in peripheral vascular intervention, including the Zilver venous stent, directly competitive with Optimed's venous and arterial stent product families.
• W. L. Gore & Associates: Privately held US manufacturer of vascular intervention products including the Viabahn covered stent, directly comparable to Optimed's peripheral arterial stent and venous stent offerings.

Broad incumbents

• Medtronic: Global medical device leader with peripheral vascular intervention products, including stents and PTA balloons that compete with Optimed's sinus-XL arterial stent system and NyloTrack+ balloon catheter.
• Boston Scientific: Major US-listed medical device incumbent with a leading peripheral intervention portfolio including the VICI venous stent system, directly competing with Optimed's sinus-Venous and sinus-Obliquus venous stent systems and broader peripheral arterial stent portfolio.
• Becton Dickinson (BD): Large diversified medical device incumbent with peripheral vascular and urology portfolios that overlap directly with Optimed's stent and ureteral stent lines, and operates at global scale with direct hospital sales forces.
• B. Braun: Large German-headquartered medical device and pharmaceutical company with vascular intervention and interventional accessories, comparable as a scaled German medtech peer with global distribution.
• Abbott: Diversified medical device incumbent with a peripheral vascular intervention business (Abbott Vascular) competing with Optimed across arterial stents, PTA balloons, and related accessories.

Emerging players

• AndraMed: German emerging specialist in peripheral and venous intervention devices (such as the Vici venous stent platform), comparable to Optimed as a focused European competitor in dedicated venous stent technology.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Optimed